145 results
Page 5 of 8
8-K/A
EX-99.1
ids50
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
93oo3e20a3
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
nwe49uk4
7 Jan 19
Other Events
7:40am
8-K
EX-99.1
l7rk3i
7 Jan 19
Other Events
7:40am
8-K
EX-99.1
h4at66gba zcdtgwn3
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.1
kb0losuj 7fo87qwly
22 Oct 18
Other Events
8:38am
8-K
EX-99.1
8alxj7q07r7f
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
7igioidr05 93hx148ih
15 Aug 18
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
7:39am
8-K
EX-99.1
rieng20hs4ad9qtkt4e
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
8-K
lck9yvm
18 Jul 18
Other Events
5:01pm
8-K
EX-99.1
mc0g3wz9dm8ui8rbfv
18 Jul 18
Other Events
5:01pm
S-3ASR
4q8q6hjbukuxk
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
ljtlzn9 vso151
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am